Sana Biotechnology, Inc. (SANA) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 9 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for SANA is $9.00, representing a +158.6% upside from the current price of $3.48. Price targets range from a low of $7.00 to a high of $12.00.
